AU4993893A - Compositions for treating and inhibiting gastric and duodenal ulcers - Google Patents

Compositions for treating and inhibiting gastric and duodenal ulcers

Info

Publication number
AU4993893A
AU4993893A AU49938/93A AU4993893A AU4993893A AU 4993893 A AU4993893 A AU 4993893A AU 49938/93 A AU49938/93 A AU 49938/93A AU 4993893 A AU4993893 A AU 4993893A AU 4993893 A AU4993893 A AU 4993893A
Authority
AU
Australia
Prior art keywords
compositions
treating
duodenal ulcers
inhibiting gastric
gastric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU49938/93A
Inventor
Dennis H Langer
Edward J Mcguire
Stephen Roth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neose Technologies Inc
Original Assignee
Neose Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neose Technologies Inc filed Critical Neose Technologies Inc
Publication of AU4993893A publication Critical patent/AU4993893A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU49938/93A 1992-07-31 1993-07-29 Compositions for treating and inhibiting gastric and duodenal ulcers Abandoned AU4993893A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92251992A 1992-07-31 1992-07-31
US922519 1992-07-31
PCT/US1993/007010 WO1994003184A1 (en) 1992-07-31 1993-07-29 Compositions for treating and inhibiting gastric and duodenal ulcers

Publications (1)

Publication Number Publication Date
AU4993893A true AU4993893A (en) 1994-03-03

Family

ID=25447150

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49938/93A Abandoned AU4993893A (en) 1992-07-31 1993-07-29 Compositions for treating and inhibiting gastric and duodenal ulcers

Country Status (3)

Country Link
AU (1) AU4993893A (en)
TW (1) TW251237B (en)
WO (1) WO1994003184A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU9502497D0 (en) * 1993-02-26 1995-10-30 Normark Use of oligosaccharide glycosides as inhibitors of bacterial adherence
JP3179108B2 (en) * 1994-03-02 2001-06-25 ネオーズ テクノロジーズ，インコーポレーテッド Methods for treating and inhibiting gastric and duodenal ulcers
SE9401826D0 (en) * 1994-05-27 1994-05-27 Pharmacia Ab Anti-Helicobacter pyroli substance
US5665561A (en) * 1994-06-06 1997-09-09 The Rockefeller University Modulators of pneumococcal adherence to pulmonary and vascular cells and diagnostic and therapeutic applications
FR2721612B1 (en) * 1994-06-23 1996-08-09 Idm New oligoside derivatives, their preparation process and their applications.
WO1997023207A1 (en) * 1995-12-22 1997-07-03 Teikoku Chemical Industries Co., Ltd. Anti-helicobacter pylori agent
EP0918526A1 (en) * 1996-05-03 1999-06-02 Neose Technologies, Inc. Bismuth salt of sialyloligosaccharide and a method for treating and inhibiting gastric and duodenal ulcers with same
US6096725A (en) * 1997-07-02 2000-08-01 Neose Technologies, Inc. Methods of using αGal oligosaccharides as immune system targeting agents
CA2418214A1 (en) * 2000-07-17 2002-01-24 Hansa Medical Ab Antimicrobial agent
WO2008084561A1 (en) 2007-01-12 2008-07-17 Shinshu University HELICOBACTER PYLORI GROWTH INHIBITOR CONTAINING α-N-ACETYLGLUCOSAMINYL-BINDING MONOSACCHARIDE DERIVATIVE
EP2345656B1 (en) 2008-10-10 2018-05-02 The Noguchi Institute N-acetylglucosaminyl beta-linked monosaccharide derivative as a helicobacter pylori bacterium proliferation inhibitor
RU2410100C2 (en) * 2009-03-30 2011-01-27 Александр Владимирович Диковский Pharmaceutical composition of proton pump inhibitor and prebiotic for treating gastric and duodenal ulcers
IT1394503B1 (en) * 2009-04-06 2012-07-05 Inalco Spa SALTS OF 6'-SIALILLATTOSE AND PROCESS FOR THEIR SYNTHESIS AND FOR THE SYNTHESIS OF OTHER ALPHA-SIALYLOLIGOSACCHARIDES.
EP2593467A4 (en) * 2010-07-14 2014-03-12 Vancouver Biotech Ltd Carbohydrate hapten-based anti-cancer vaccines and antibody drugs
RU2501549C1 (en) 2012-08-30 2013-12-20 Авва Девелопмент Лтд Pharmaceutical composition for treating gastroesophageal reflux disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2196252B (en) * 1986-09-18 1990-10-17 London Pharmacy Innovation Gastric controlled-release dosage forms
US4935406A (en) * 1988-09-20 1990-06-19 Marion Laboratories, Inc. Use of bismuth (phosph/sulf)ated saccharides against Camplyobacter-associated gastrointestinal disorders

Also Published As

Publication number Publication date
TW251237B (en) 1995-07-11
WO1994003184A1 (en) 1994-02-17

Similar Documents

Publication Publication Date Title
AU4225093A (en) Methods and pharmaceutical compositions for treating episodic heartburn
AU3930493A (en) Use of H-2 antagonists for treatment of gingivitis
GB9208339D0 (en) Treatment composition
AU4993893A (en) Compositions for treating and inhibiting gastric and duodenal ulcers
AU2986392A (en) Medicaments for treating inflammatory conditions or for analgesia
AU6946594A (en) Methods for the treatment and prevention of diarrhea
AU1912992A (en) Method for treating hypothermia
AU1097192A (en) Treatment of particulate material
AU1932395A (en) Method for treating and inhibiting gastric and duodenal ulcers
AU6927894A (en) 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions
AU5270693A (en) Pharmaceutical composition for preventing or treating arteriosclerosis
AU1429792A (en) Method for the treatment of the sewages and respective plant
AU5289293A (en) Semiconductor component
AU3473193A (en) Treatment for atherosclerosis
AU2347192A (en) Oak and carob bark composition for relieving gastric ulcers
AU5957794A (en) Compositions and method for the inhibition of phagocytes
AU1097892A (en) Process and installation for the treatment of steel-mill slag
AU5160590A (en) Composition and method for treatment of gastric and duodenal ulcers and mucosal erosions
AU2732697A (en) Bismuth salt of sialyloligosaccharide and a method for treating and inhibiting gastric and duodenal ulcers with same
AU7691291A (en) Method of treating gastric ulcers and obesity
AU7042794A (en) Ulcer treating composition
AU1378495A (en) Methods and compositions for inhibiting thrombogenesis
AU5699594A (en) Use of alkylthiopyridines for controlling helicobacter bacteria
AUPM836794A0 (en) Improved method and composition for the treatment of ulcers
IE881353L (en) Compositions for treating duodenal ulcers